The influence of neuroinflammation in Autism Spectrum Disorder

SM Matta, EL Hill-Yardin, PJ Crack - Brain, behavior, and immunity, 2019 - Elsevier
Abstract Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder characterised
by deficits in social communication and restricted or repetitive behaviours. The clinical …

Cytokines and brain excitability

MA Galic, K Riazi, QJ Pittman - Frontiers in neuroendocrinology, 2012 - Elsevier
Cytokines are molecules secreted by peripheral immune cells, microglia, astrocytes and
neurons in the central nervous system. Peripheral or central inflammation is characterized …

PDGFRβ cells rapidly relay inflammatory signal from the circulatory system to neurons via chemokine CCL2

L Duan, XD Zhang, WY Miao, YJ Sun, G Xiong, Q Wu… - Neuron, 2018 - cell.com
Acute infection, if not kept in check, can lead to systemic inflammatory responses in the
brain. Here, we show that within 2 hr of systemic inflammation, PDGFRβ mural cells of blood …

A systematic analysis of the peripheral and CNS effects of systemic LPS, IL-1β, TNF-α and IL-6 challenges in C57BL/6 mice

DT Skelly, E Hennessy, MA Dansereau… - PloS one, 2013 - journals.plos.org
It is increasingly clear that systemic inflammation has both adaptive and deleterious effects
on the brain. However, detailed comparisons of brain effects of systemic challenges with …

Inflammatory cytokines: potential biomarkers of immunologic dysfunction in autism spectrum disorders

N Xu, X Li, Y Zhong - Mediators of inflammation, 2015 - Wiley Online Library
Autism is a disorder of neurobiological origin characterized by problems in communication
and social skills and repetitive behavior. After more than six decades of research, the …

Mesenchymal stem cells and conditioned media in the treatment of multiple sclerosis patients: Clinical, ophthalmological and radiological assessments of safety and …

S Dahbour, F Jamali, D Alhattab… - CNS neuroscience & …, 2017 - Wiley Online Library
Aims This open‐label prospective phase I/II a clinical study used autologous bone marrow‐
derived mesenchymal stromal cells (BM‐MSC s) followed by mesenchymal stromal cells …

Dual CCR5/CCR2 targeting: opportunities for the cure of complex disorders

L Fantuzzi, M Tagliamonte, MC Gauzzi… - Cellular and molecular life …, 2019 - Springer
The chemokine system mediates acute inflammation by driving leukocyte migration to
damaged or infected tissues. However, elevated expression of chemokines and their …

Toward identifying key mechanisms of progression in multiple sclerosis

L Husseini, A Geladaris, MS Weber - Trends in Neurosciences, 2024 - cell.com
A major therapeutic goal in the treatment of multiple sclerosis (MS) is to prevent the
accumulation of disability over an often decades-long disease course. Disability progression …

Immune treatments for alcohol use disorder: A translational framework

LR Meredith, EM Burnette, EN Grodin, MR Irwin… - Brain, behavior, and …, 2021 - Elsevier
While the immune system is essential for survival, an excessive or prolonged inflammatory
response, such as that resulting from sustained heavy alcohol use, can damage the host …

CCL2/MCP-1 modulation of microglial activation and proliferation

AE Hinojosa, B Garcia-Bueno, JC Leza… - Journal of …, 2011 - Springer
Background Monocyte chemoattractant protein (CCL2/MCP-1) is a chemokine that attracts
cells involved in the immune/inflammatory response. As microglia are one of the main cell …